什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001599882
申报总市值
US$10.6亿
US$10.6亿
95 檔
20.0%
Rhenman & Partners Asset Management AB 在 Q3 2024 季度的美股仓位总计估值为 US$10.6亿,分散于 95 个持仓标的之中,反映其市场参与广度与投资规模。
Rhenman & Partners Asset Management AB 在 Q3 2024 进行了结构性的板块轮动与仓位换股。在开立 8 个全新仓位及加仓 39 档持股的同时,亦同步清仓 6 档并减仓 39 档标的。
在资产配置集中度方面,Rhenman & Partners Asset Management AB 的前 5 大核心持股(包含 BSX, UNH, LLY 等)合计占整体申报市值的 20.0%,反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BSX | Boston Scientific CORP | 股票-医疗保健 | 4.01% | -3.03% | -0.84% | |
| 2 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 3.45% | +2.15% | -30.96% | |
| 3 | LLY | Eli Lilly & Co | 股票-医疗保健 | 3.42% | -1.30% | +1.06% | |
| 4 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 3.33% | -2.98% | +21.88% | |
| 5 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 2.99% | +0.24% | -3.32% | |
| 6 | PRCT | Procept Biorobotics CORP | 股票-其他 | 2.89% | -0.73% | +1.14% | |
| 7 | ABBV | Abbvie Inc | 股票-医疗保健 | 2.84% | +0.38% | -6.35% | |
| 8 | MDT | Medtronic plc | 股票-医疗保健 | 2.69% | +0.11% | +76.92% | |
| 9 | EXK | Exact Sciences CORP | 股票-原材料 | 2.57% | — | +220.69% | |
| 10 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.51% | — | -7.04% | |
| 11 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 2.51% | -0.80% | +4.13% | |
| 12 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 2.49% | -0.75% | +53.67% | |
| 13 | NTRA | Natera Inc | 股票-医疗保健 | 2.38% | +0.29% | +47.13% | |
| 14 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 2.36% | +0.13% | -28.08% | |
| 15 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 2.22% | +2.59% | NEW | |
| 16 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 2.20% | — | -0.44% | |
| 17 | ELV | Elevance Health Inc | 股票-医疗保健 | 2.13% | +0.10% | -41.14% | |
| 18 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 2.09% | — | +617.65% | |
| 19 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 2.08% | +0.13% | +44.93% | |
| 20 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 2.04% | -0.07% | -26.45% | |
| 21 | ALHC | Alignment Healthcare Inc | 股票-其他 | 1.90% | -0.05% | +20.46% | |
| 22 | DHR | Danaher CORP | 股票-医疗保健 | 1.88% | +1.02% | +71.76% | |
| 23 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 1.80% | -0.96% | -11.57% | |
| 24 | RPRX | Royalty Pharma plc | 股票-医疗保健 | 1.41% | -0.34% | +12.63% | |
| 25 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 1.26% | -1.02% | +4.58% | |
| 26 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.25% | -0.60% | -6.90% | |
| 27 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 1.22% | — | +44.72% | |
| 28 | MCK | Mckesson CORP | 股票-医疗保健 | 1.21% | -0.62% | +0.39% | |
| 29 | GKOS | Glaukos CORP | 股票-医疗保健 | 1.17% | +0.45% | +122.00% | |
| 30 | CI | THE Cigna Group | 股票-医疗保健 | 1.17% | +0.19% | -43.80% | |
| 31 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.14% | +0.84% | -2.65% | |
| 32 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 1.12% | -0.92% | -41.11% | |
| 33 | DVAX | Dynavax Technologies CORP | 股票-其他 | 1.08% | — | -3.44% | |
| 34 | BIIB | Biogen Inc | 股票-医疗保健 | 1.06% | -0.54% | -20.87% | |
| 35 | NVO | Novo-nordisk A/s-spons Adr | 股票-医疗保健 | 0.97% | — | — | |
| 36 | CVS | Cvs Health CORP | 股票-医疗保健 | 0.94% | -0.25% | — | |
| 37 | IQV | Iqvia Holdings Inc | 股票-医疗保健 | 0.92% | -1.12% | EXIT | |
| 38 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 0.89% | +0.13% | -3.92% | |
| 39 | APLSUSD | Apellis Pharmaceuticals Inc | 股票-其他 | 0.86% | — | +563.42% | |
| 40 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 0.84% | +0.22% | -18.42% | |
| 41 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.83% | +0.47% | NEW | |
| 42 | COR | Cencora Inc | 股票-医疗保健 | 0.82% | -0.78% | -12.33% | |
| 43 | IOVA | Iovance Biotherapeutics Inc | 股票-其他 | 0.80% | -0.22% | +14.40% | |
| 44 | HUM | Humana Inc | 股票-医疗保健 | 0.80% | — | — | |
| 45 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 0.77% | — | -8.61% | |
| 46 | INSM | Insmed Inc | 股票-医疗保健 | 0.77% | -1.69% | +30.15% | |
| 47 | PODD | Insulet CORP | 股票-医疗保健 | 0.76% | +0.24% | -13.98% | |
| 48 | NUVL | Nuvalent Inc-a | 股票-其他 | 0.75% | -1.03% | EXIT | |
| 49 | CNC | Centene CORP | 股票-医疗保健 | 0.71% | +1.48% | NEW | |
| 50 | SYK | Stryker CORP | 股票-医疗保健 | 0.67% | -0.01% | +27.78% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | EXK | Exact Sciences CORP | +2% | +220.69% | 加仓 |
| 2 | INSP | Inspire Medical Systems Inc | +1.9% | +617.65% | 加仓 |
| 3 | MDT | Medtronic plc | +1.1% | +76.92% | 加仓 |
| 4 | NVO | Novo-nordisk A/s-spons Adr | +1% | NEW | 新建仓 |
| 5 | CVS | Cvs Health CORP | +0.9% | NEW | 新建仓 |
| 6 | GILD | Gilead Sciences Inc | +0.9% | +53.67% | 加仓 |
| 7 | HUM | Humana Inc | +0.8% | NEW | 新建仓 |
| 8 | NTRA | Natera Inc | +0.8% | +47.13% | 加仓 |
| 9 | DHR | Danaher CORP | +0.7% | +71.76% | 加仓 |
| 10 | ALHC | Alignment Healthcare Inc | +0.7% | +20.46% | 加仓 |
| 11 | APLSUSD | Apellis Pharmaceuticals Inc | +0.7% | +563.42% | 加仓 |
| 12 | MOH | Molina Healthcare Inc | +0.6% | +322.86% | 加仓 |
| 13 | GKOS | Glaukos CORP | +0.6% | +122.00% | 加仓 |
| 14 | EVH | Evolent Health Inc - A | +0.5% | +430.00% | 加仓 |
| 15 | BNTX | Biontech Se-adr | +0.5% | NEW | 新建仓 |
| 16 | TMDX | Transmedics Group Inc | +0.4% | +235.33% | 加仓 |
| 17 | GERN | Geron CORP | +0.4% | NEW | 新建仓 |
| 18 | DNTH | Dianthus Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 19 | PRCT | Procept Biorobotics CORP | +0.3% | +1.14% | 加仓 |
| 20 | ITCIEUR | Intra-cellular Therapies Inc | +0.3% | +44.72% | 加仓 |
| 21 | IQV | Iqvia Holdings Inc | +0.3% | +54.84% | 加仓 |
| 22 | ACHC | Acadia Healthcare Co Inc | +0.3% | +165.54% | 加仓 |
| 23 | IMVT | Immunovant Inc | +0.2% | +86.21% | 加仓 |
| 24 | ACLXGBX | Arcellx Inc | +0.2% | NEW | 新建仓 |
| 25 | BRKR | Bruker CORP | +0.2% | +638.58% | 加仓 |
| 26 | NRIX | Nurix Therapeutics Inc | +0.2% | +72.03% | 加仓 |
| 27 | NUVL | Nuvalent Inc-a | +0.2% | +8.76% | 加仓 |
| 28 | IDYA | Ideaya Biosciences Inc | +0.2% | +138.32% | 加仓 |
| 29 | UHS | Universal Health Services-b | +0.2% | NEW | 新建仓 |
| 30 | MRK | Merck & Co. Inc. | +0.1% | +37.71% | 加仓 |
| 31 | INSM | Insmed Inc | +0.1% | +30.15% | 加仓 |
| 32 | RLAY | Relay Therapeutics Inc | +0.1% | +100.00% | 加仓 |
| 33 | 1K0 | Igm Biosciences Inc | +0.1% | -4.89% | 减仓 |
| 34 | REGN | Regeneron Pharmaceuticals | +0.1% | +21.88% | 加仓 |
| 35 | BBIO | Bridgebio Pharma Inc | +0.1% | +45.26% | 加仓 |
| 36 | MEDP | Medpace Holdings Inc | +0.1% | +200.00% | 加仓 |
| 37 | BMRN | Biomarin Pharmaceutical Inc | +0.1% | +44.93% | 加仓 |
| 38 | IOVA | Iovance Biotherapeutics Inc | +0.1% | +14.40% | 加仓 |
| 39 | SYK | Stryker CORP | +0.1% | +27.78% | 加仓 |
| 40 | THC | Tenet Healthcare CORP | +0.1% | -3.32% | 减仓 |
| 41 | IONS | Ionis Pharmaceuticals Inc | 0% | +50.00% | 加仓 |
| 42 | RPRX | Royalty Pharma plc | 0% | +12.63% | 加仓 |
| 43 | RGEN | Repligen CORP | — | — | 不变 |
| 44 | TMO | Thermo Fisher Scientific Inc | 0% | +4.58% | 加仓 |
| 45 | EHC | Encompass Health CORP | 0% | +1.67% | 加仓 |
| 46 | EPIEUR | Essa Pharma Inc | 0% | -0.17% | 减仓 |
| 47 | TECH | Bio-techne CORP | 0% | — | 不变 |
| 48 | PLRX | Pliant Therapeutics Inc | 0% | — | 不变 |
| 49 | HCA | Hca Healthcare Inc | 0% | -7.04% | 减仓 |
| 50 | XENE | Xenon Pharmaceuticals Inc | 0% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案,Rhenman & Partners Asset Management AB 在 Q3 2024 季度的美股持仓总市值约为 US$10.6亿,共申报了 95 个公开持股仓位。
在 Q3 2024 季度,Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分别为:BSX (4.0%)、UNH (3.5%)、LLY (3.4%)。其中最大持股仓位 BSX 占据整体投资组合约 4.0% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
NVO
市值: US$1190.7万
本季最大获利了结 / 清仓标的
EW
前期市值: US$900.6万
在 Q3 2024 季度中,Rhenman & Partners Asset Management AB 共进行了 92 项持仓异动,包含新建仓 8 个仓位、加仓 39 个仓位、减仓 39 个仓位以及清仓 6 个仓位。 其中最大新建仓标的为 NVO。 本季清仓仓位包含 EW。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报,掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。